Min Kang

7PUBLICATIONS
3CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMajor global burdens of disease
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jun 24, 2024
Immune checkpoint inhibitor combined with chemotherapy versus chemotherapy alone in the first-line treatment for recurrent or metastatic nasopharyngeal carcinoma: a meta-analysis of random controlled trials.

Shuangyue Wang, Xiaojie Huang, Rong Li

|Jan 27, 2023
Nomogram to Predict Long-Term Overall Survival and Cancer-Specific Survival of Radiotherapy Patients with Nasopharyngeal Carcinoma.

Zhiru Li, Chao Li, Dong Yang

|Jul 29, 2022
Efficacy of concurrent chemoradiotherapy plus Endostar compared with concurrent chemoradiotherapy in the treatment of locally advanced nasopharyngeal carcinoma: a retrospective study.

Yuanxiu Yin, Ziyan Zhou, Zhiru Li

|Jun 27, 2022
Demographics and Economic Burden of Nasopharyngeal Carcinoma Inpatients.

Dong Yang, Nengfu Bin, Ziyan Zhou

|Mar 02, 2022
Investigation of miR-21-5p Key Target Genes and Pathways in Head and Neck Squamous Cell Carcinoma Based on TCGA Database and Bioinformatics Analysis.

Mingjun Shen, Ziyan Zhou, Bai Bei Li

|Apr 13, 2021
Bioinformatics analysis of the expression and role of microRNA-221-3p in head and neck squamous cell carcinoma.

Ziyan Zhou, Wenling Wu, Jixi Li

Pageof 2

Frequent Collaborators

2 joint publications

Ziyan Zhou

2 joint publications

Dong Yang

1 joint publications

Zhiru Li